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Abstract
Background: Auditory hair cells spontaneously regenerate following injury in birds but not mammals. A better
understanding of the molecular events underlying hair cell regeneration in birds may allow for identification and eventually
manipulation of relevant pathways in mammals to stimulate regeneration and restore hearing in deaf patients.
Methodology/Principal Findings: Gene expression was profiled in forskolin treated (i.e., proliferating) and quiescent control
auditory epithelia of post-hatch chicks using an Affymetrix whole-genome chicken array after 24 (n=6), 48 (n=6), and 72
(n=12) hours in culture. In the forskolin-treated epithelia there was significant (p,0.05; .two-fold change) upregulation of
many genes thought to be relevant to cell cycle control and inner ear development. Gene set enrichment analysis was
performed on the data and identified myriad microRNAs that are likely to be upregulated in the regenerating tissue,
including microRNA181a (miR181a), which is known to mediate proliferation in other systems. Functional experiments
showed that miR181a overexpression is sufficient to stimulate proliferation within the basilar papilla, as assayed by BrdU
incorporation. Further, some of the newly produced cells express the early hair cell marker myosin VI, suggesting that
miR181a transfection can result in the production of new hair cells.
Conclusions/Significance: These studies have identified a single microRNA, miR181a, that can cause proliferation in the
chicken auditory epithelium with production of new hair cells.
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Introduction
Sensorineural hearing loss represents a major public health
concern. Approximately 300 million people worldwide have
moderate to profound hearing loss in both ears [1]. Loss of inner
ear hair cells, which serve to transduce sound into neural impulses,
is responsible for the majority of hearing loss. In humans, and
other mammals, loss of hair cells is permanent since these
organisms have no capacity for hair cell regeneration. In contrast,
other non-mammalian vertebrates such as birds, reptiles, amphib-
ian and fish are able to replace lost hair cells.
The basilar papilla, the avian auditory epithelium, is able to
regenerate hair cells in response to hair cell loss (reviewed in [2]).
However, the auditory epithelium shows no mitotic activity
normally, a feature that is reminiscent of the mammalian auditory
epithelium, and contrasts with the chick vestibular epithelium
which shows continuous mitotic activity [3]. Thus, the avian
auditory epithelium can be viewed as an intermediary in the
evolution from the fish to the mammal, and we reason that the
study of this epithelium will provide insight into why the
mammalian auditory epithelium shows mitotic quiescence at rest
(similar to the avian auditory epithelium), but is unable to
proliferate in response to damage (in contrast to the avian auditory
epithelium).
The basilar papilla is comprised of both sensory transducing hair
cells and supporting cells. Following injury, it is the supporting cells
which give rise to new hair cells [4,5]. For example, exposure of
birds to intense noise causes some supporting cells to leave growth-
arrest, re-enter the cell cycle and ultimately differentiate into hair
cells[6,7,8,9].Newhaircellsarefirstseen 4–5 daysaftertheonsetof
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by 20–28 days after stimulus onset they are virtually indistinguish-
able fromunaffected cells[11].Inaddition,somenewhaircellsarise
from direct differentiation of supporting cells without an intervening
mitotic step [12,13,14,15,16,17,18,19]. After acoustic or ototoxic
insult, birds initially have increased hearing thresholds, which
eventually return nearly to baseline confirming that newly produced
hair cells are functional [20]. It is believed that this recovery of
function results from both regeneration of new hair cells as well as
repair of those that have survived [21].
Though the intracellular pathways required for hair cell
regeneration have not yet been fully elucidated, various pathways
and signaling cascades have been implicated in this process. For
example, it has been shown that treatment of the chick basilar
papilla with forskolin, a potent adenylate cyclase activator that
increases intracellular cAMP levels, causes a robust and wide-
spread proliferation of supporting cells, leading to the production
of new hair cells [22]. This effect is first seen after 72 hours in
culture, occurs without upregulation of markers of apoptosis, and
is significantly blocked by protein kinase A inhibitors. It therefore
appears as though activation of this pathway can stimulate growth
of new hair cells with limited cell injury. Forskolin also appears to
have a mitogenic effect in the mammalian vestibular system, in
which brief treatment with this compound results in an increase an
supporting cell S-phase entry [23]. Moreover, the same study
found that this effect is blocked by brief treatment with forskolin in
the presence of monensin or bafilmycin, which inhibit recycling of
membrane receptors. Increased cAMP levels may therefore lead to
proliferation by causing upregulation of tyrosine kinase growth
factor receptors. With age-related hearing loss in humans there is a
substantial loss of hair cells within the organ of Corti [24], so it is
likely that a robust proliferative process that produces new hair
cells is what will ultimately lead to maximal recovery of function in
hearing impaired patients. In the present study, microarrays were
used to analyze gene expression in forskolin treated basilar papillae
given the robustness of this effect.
In other systems, microarray analysis of differing phenotypes
has revealed complex differences in mRNA expression. These
complex differences are likely brought about by the combined
activity of transcription factors and microRNAs (miRNAs) that
regulate expression of multiple genes and specific genetic
programs. In fact, a study of transcription factor expression in
regenerating versus non-regenerating chicken basilar papillae
revealed a number of transcription factors that were differentially
expressed [25].
MiRNAs are a species of small regulatory RNA that bind to
complementary sequences in mRNA and decrease gene expression
by increasing degradation and blocking translation (reviewed in
[26]). Though each miRNA binds a specific sequence, these
molecules are promiscuous in that their complementary sequences
are found in a number of different mRNAs [27]. As a result,
miRNA expression may represent a way in which cells can rapidly
and in a coordinated fashion up- or downregulate a large number
of genes. Some miRNAs are known to be important for inner ear
development [28,29,30,31] and may play a role in hair cell
regeneration, where there is presumably some reiteration of
developmental events. However there have been few published
studies on the role of miRNAs in auditory hair cell regeneration,
specifically. One study revealed that the let-7 family of miRNA are
downregulated in the newt inner ear after hair cell injury [32].
This particular study underscores the importance of examining
more closely the role of miRNA in hair cell regeneration.
In order to gain insight into the molecular events which underlie
auditory hair cell regeneration in chicken, we compared gene
expression in forskolin treated (i.e., proliferating) and control (i.e.,
quiescent) auditory epithelia using Affymetrix whole genome
chicken microarrays. The microarray data were validated by
quantitative PCR. Gene set enrichment analyses were performed
to identify miRNAs and transcription factors that may be
important for hair cell regeneration. Many sets of genes
representing predicted targets of specific miRNAs were found to
be significantly enriched among genes downregulated in the
forskolin-treated sensory epithelia after 72 hours, suggesting that
these miRNAs were likely upregulated in the proliferating tissue.
One of these microRNAs, miR181a, was selected for functional
experiments given its role in proliferation and suppression of the
cell cycle inhibitor p27 in human myeloid leukemia cells [33]. P27
is thought to represent a key barrier to hair cell regeneration in the
mammalian inner ear [34,35]. Basilar papillae transfected with a
miR181a precursor had increased numbers of BrdU positive cells
than epithelia that were transfected with a non-targeting miRNA.
Some cells labeling for BrdU also expressed the early hair cell
marker myosin VI, indicating that overexpression of miR181a is
capable of producing proliferation with production of new hair
cells.
Materials and Methods
Basilar papilla explant cultures
Animals were treated in accordance with policies set forth by
the Yale Institutional Animal Care and Use Committee (protocol
number 2007-10439). Under sterile conditions, cochlear ducts
containing the basilar papillae were carefully dissected out of 0-
day-old chicks and then individually cultured in DMEM with 10%
fetal bovine serum with or without forskolin (final concentration
100 mM, delivered in 1% DMSO) for either 24, 48, or 72 hours at
37uC with 5% CO2. Control samples received DMSO at 1% as a
vehicle control. At the end of 72 hours, the tegmentum
vasculosum was dissected off to expose the auditory epithelium,
which was delicately freed from the underlying cartilaginous
plates. All explants were kept in culture for 72 hours because new
hair cells are first seen in basilar papillae treated with forskolin
after ,72 hours of exposure to the small molecule [22].
Therefore, at even earlier time points in culture the molecular
events that underlie hair cell proliferation are well underway. Each
sample was comprised of three auditory epithelia from three
different chicks and were put in 100 mL of DMEM and then
immediately frozen at 280uC until RNA isolation could be
performed. There were a total of 24 samples in this experiment:
three 24-hour forskolin, three 24-hour control, three 48-hour
forskolin, three 48-hour control, six 72-hour forskolin and six 72-
hour control.
RNA isolation
Immediately upon removal of the frozen epithelia samples from
the 280uC freezer, the lysis buffer from the RNAqueousH Kit
(Ambion, Austin, TX) was added. Given the small amount of
tissue and relatively large surface area to size ratio, no measures to
actively disrupt or homogenize the tissue in each sample were
necessary. Total RNA isolation then proceeded as directed by the
RNAqueousH Kit manual. Sample quality was confirmed by gel
analysis.
Microarray experiments
Double-stranded cDNA and biotin-labeled cRNA were synthe-
sized from 1 to 5 mg of total RNA using a two-cycle target labeling
kit [36]. Biotin-labeled cRNA was purified using the GeneChip
Cleanup Module prior to fragmenting to a size of 35–200 bases by
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Tris-acetate, pH 8.1, 100 mM potassium acetate, 30 mM magne-
sium acetate). Hybridization of the samples with Affymetrix chicken
arrays was then performed at the Yale University Keck Facility
according to the manufacturer’s protocol [37]. All microarray data
is MIAME compliant and has been uploaded to MIAMExpress
(ArrayExpress accession: E-MEXP-2642, username=Reviewer_
E-MEXP-2642, password=1269882335242).
Differential gene expression analysis
The microarray gene expression analysis was performed using
GeneSpring GX 9.0 software (Agilent Technologies, Santa Clara,
CA). The data were GC-RMA normalized without baseline
transformation, and then filtered by expression (20%–100% in at
least one of the six or twelve samples at each time point) to exclude
genes expressed only at very low levels in all samples. Median
expression values were used for redundant probe sets. Genes
differentially expressed were identified by using a fold-change
cutoff of 2 and then performing an unpaired t-test after Benjamini-
Hotchberg correction for multiple comparisons (p,0.05). Heat
maps were generated using R version 2.10.1 (www.r-project.org)
using the HeatPlus add-on in the Bioconductor package.
Quantitative PCR validation of microarray gene
expression data
In order to validate the microarray data, twelve genes were
selected to be verified by qPCR. Seven of the genes selected were
upregulated and five were downregulated in the forskolin
condition. The upregulated genes validated by qPCR were highly
expressed in at least one condition and chosen to span a range in
fold-change differences between the two experimental conditions
at 72 hours, from 2.0 to 64.3. The 12 genes that were validated
are BECN1, CCNI, CDKN1B (p27), CDKN2B, DPM1, EME1,
FBXO8, ITGA4, NLGN1, OCM, PIGW, SNX1. Additionally,
expression of the 18S ribosomal subunit was also assessed to allow
for normalization of total RNA levels between samples using the
2
2DDC
T method [38]. Primers were designed using MacVector
(MacVector, Cary, NC) software and Primer 3 [39] and were
validated by melting curve analysis. 5 mg of RNA was isolated
from each sample as described above and was used to create first-
strand cDNA using random hexamers and reverse transcriptase
(Superscript II; Invitrogen, Carslbad, CA), according to the
manufacturer’s instructions. Amplification was performed using
the SYBR Green Supermix kit (Bio-Rad, Hercules, CA) on an
iCycler system (Bio-Rad, Hercules, CA). Three replicates were
performed and the data averaged for each cDNA sample and
primer pair combination. Those fold-changes with a 95%
confidence interval excluding one were considered significant.
Gene sets used for enrichment analyses
Gene set enrichment analysis (GSEA) was performed to analyze
the pattern of differential gene expression between forskolin
treated and control basilar papillae using GSEA version 2 software
[40]. Three different gene set packages were used, two of which
were downloaded directly from the Broad institute website (www.
broad.mit.edu/gsea).
To identify transcription factors which may be important for hair
cell regeneration, a GSEA was performed using a gene set package
called ‘‘c3.all.v2.5.symbols,’’ which was obtained from the BROAD
Institute website. This package contains a series of gene sets defined
by the presence of transcription factor motifs and predicted miRNA
binding sites. The genes in each set of this package therefore share a
cis-regulatory motif that is conserved across human, mouse, rat, and
dog genomes and will be referred to hereafter as the ‘‘mammalian
gene sets.’’ The motifs used come from Xie et al. (2005) and the
TRANSFAC database and include sets of genes sharing a 39-UTR
miRNA binding motif [41]. Even though these gene sets are not
based on the chicken genome, we reasoned that these results would
be of interest given the known conservation of miRNA targets
among mammals [42]. We further surmised that if the conservation
of miRNA targets is poorly conserved between mammals and non-
mammalian vertebrates then an enrichment analysis might produce
no statistically significant results. Any significant findings, however,
would warrant further examination.
In order to validate the GSEA results from the analyses
performed using the mammalian gene sets, GSEA was also run
using a gene set package that was generated by scanning the
portionsofthechickengenomethat areconservedwith frog(Xenopus
tropicalis) to identify gene sets sharing particular transcription factor
motifs defined in the TRANSFAC database. These gene sets will
hereafter be referred to as the ‘‘chicken/frog conservation gene
sets.’’ Only conserved regions were used to reduce the number of
false positives, as there is evidence to suggest that transcription
factor recognition sites tend to be enriched in conserved portions of
the genome [43]. However, recent genome-wide studies have
demonstrated that many transcription factor binding sites are not
conserved [44,45] and are also found outside of the proximal
promoter region [44,46]. Thus, our approach should be considered
to be conservative in the sense that some true binding sites may be
overlooked, but those that are identified have a higher likelihood of
being functional. The frog genome in particular was used in light of
this organism’s close evolutionary relationship to chickens. The use
of conservation between more distantly related organisms, such as
chicken and mammals, would be very strict and would result in the
omission of many potentially significant positive results. To create
these gene sets we downloaded the transcription start site for all
chicken RefSeq genes, defined by the May 2008 RefGene table [47]
using the UCSC Genome Bioinformatics site (genome.ucsc.edu).
The region 2 kilobases around each transcription start site was
identified within the May 2006 genome-wide multiple alignment of
6 vertebrate species to the chicken genome [48], also available
through UCSC Genome Bioinformatics site. In order to identify
putative transcription factor binding sites, the chicken sequences,
along with aligned regions from frog, were analyzed using the
TRANSFAC MATCH algorithm with a cutoff chosen to minimize
the sum of false positives and false negatives [49]. The analysis was
performed for all vertebrate transcription factor matrices in the
2009.1 release of TRANSFAC [50], and putative binding sites were
considered to be evolutionarily conserved if matches were also
found at the aligned positions in both chicken and frog sequences
and had no gaps present in the multiple alignment of these species.
To assess the functional relevance of the pattern of differentially
expressed genes across a variety of organisms and systems, GSEA
was performed using a gene set package called ‘‘c2.all.v2.5.sym-
bols’’ which was also downloaded from the BROAD Institute
website. This package defines curated sets of genes based on
specific experimental findings from experiments on human and
model animal tissue, which includes canonical pathways and
chemical/genetic perturbations based gene sets. These gene sets
will hereafter be referred to as the ‘‘curated gene sets.’’ The
relevant reference is given on the BROAD website for each
curated gene set for assessment of relevance.
Gene set enrichment analysis
The GeneSpring processed data from the 38,535 original
probes was collapsed into 13,159 genes based on gene symbols.
Some genes were assigned to one or multiple gene sets
MiRs in Hair Cell Regeneration
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gene sets in the mammalian gene sets package, 50 of which were
excluded by gene set size criteria (15–50), leaving 783 to be
included in our analysis. 359 of the 566 chicken/frog conservation
gene sets met this size threshold criterion, as did 1,197 out of the
1,892 curated gene sets (Table 1).
Genes were first ranked by their signal-to-noise ratio between
the forskolin and control groups. In other words, the genes most
consistently overexpressed in the forskolin samples were ranked at
one end of the list and those most underexpressed in this group
were ranked at the other end. GSEA asks whether the genes that
make up a particular gene set are randomly distributed throughout
the ranked list of genes, or whether they have a tendency to cluster
at the top or bottom of the list. This question was answered by
calculating for every gene set a running sum statistic, the
maximum of which is referred to as the enrichment score (ES).
Each ES is then normalized to the size of its corresponding gene
set to produce a normalized enrichment score (NES). Statistical
significance of each NES is determined by comparing that NES to
the distribution of ESs generated by randomly permutating the
genotype class labels of the data set. Therefore, the null hypothesis
of a GSEA is that the distribution of a gene set throughout the
ranked list of genes is random with regards to the two treatment
conditions being compared. The alternative hypothesis is that
location of genes in a set is associated with the treatment
conditions. Both the p-value and false discovery rate (FDR; q-
value) were calculated for each set. Gene sets with a FDR less than
0.25 and a p-value less than 0.05 were considered differentially
expressed. The GSEA parameters used were as follows: metric=
signal to noise; permutation number=1,000; gene size mini-
mum=15; gene size maximum=500; enrichment statistic=
classic; permutation type=phenotype. One GSEA was performed
using the 24-hour control data and 72-hour control data to
negatively control for gene expression changes occurring with
culture duration, as well as false positives not reflective of the
treatment condition.
Pre-microRNA181a and anti-microRNA181a transfection
For functional miR181a experiments, basilar papilla explants
from 0-day-old chicks were cultured with or without forskolin for
72 hours as described above. Basilar papillae from both conditions
were also transfected with either a miR181a precursor (Ambion,
Austin, TX) or a non-targeting miRNA which served as a negative
control (Ambion, Austin, TX) at a final concentration of 100 nM.
Transfections were performed for six hours in serum-free medium
which was eventually replaced with regular medium. BrdU was
present at a concentration of 0.01% for the entire culture duration,
except for the six-hour transfection. Some basilar papillae were
also cultured for 24 hours with forskolin as described above and
then transfected with anti-miR181a (Ambion, Austin, TX) to
suppress endogenous miR181a. Transfections were performed
using the lipid-based X-tremeGENE SiRNA Transfection
Reagent (Roche, Indianapolis, IN) per the manufacturer’s
instructions.
Antibody labeling
After 72 hours in culture basilar papillae were fixed in 4% PFA
in PBS for 30 minutes. All fixative was removed by three 5-minute
washes in PBS. The tissue was blocked and permeabilized using a
solution of PBS with FBS (10%) and Triton-X (0.1%) for one hour.
Each basilar papilla was then incubated with mouse anti-BrdU
antibodies (1:40, BD, Franklin Lakes, NJ) in PBS for one hour.
After washing with PBS, alkaline phosphatase-conjugated goat
anti-mouse IgG (1:400, Santa Cruz, Santa Cruz, CA) in PBS with
Triton-X (0.1%) was added for one hour. After washing in PBS,
alkaline phosphatase substrate was produced using the NBT/
BCIP Reagent Kit (Invitrogen, Carlsbad, CA) per the manufac-
turer’s instructions and then added to the tissue for approximately
five minutes. All substrate was then thoroughly washed with PBS.
Statistics
Basilar papillae immunohistochemically labeled for BrdU were
viewed using brightfield microscopy and were imaged using a
digital camera attached to a Zeiss Stemi SV 11 stereoscope. The
borders of the sensory epithelium were easily viewed both by direct
microscopy and in the captured images. The intraepithelial
location of BrdU positive nuclei was confirmed through focal
plane adjustments. Only those nuclei which were clearly within the
epithelium were counted. Unpaired Student’s t-tests were
performed to determine the statistical significance of the
comparisons discussed in the text using a cut-off of p,0.05.
Co-labeling experiments
To determine whether any newly produced BrdU positive cells
express the early hair cell marker myosin VI, some basilar papillae
were transfected with pre-miR181a as described above and
Table 1. Gene set enrichment analysis results.
Gene Set Package Statistic Description 24H FSK 24H CTL 48H FSK 48H CTL 72H FSK 72H CTL
Mammalian Up/Total 407/783 376/783 512/783 271/783 146/783 636/783
p,0.05 72 26 165 29 37 210
q,0.25 66 0 198 5 41 331
Conservation Up/Total 323/359 36/359 256/359 103/359 219/359 140/359
p,0.05 176 2 127 22 95 31
q,0.25 230 0 162 53 128 45
Curated Up/Total 691/1,197 507/1,197 778/1,197 419/1,197 695/1,197 502/1,197
p,0.05 240 136 364 94 231 216
q,0.25 323 152 495 114 285 346
The number of mammalian miRNA/transcription factor motif based (‘‘Mammalian’’), chicken/frog conservation transcription factor motif based genes e t s
(‘‘Conservation’’), and curated gene sets from the BROAD Institute (‘‘Curated’’) meeting the criteria p,0.05 and q (false discovery rate) ,0.25 for forskolin (FSK) and
control (CTL) samples after 24, 48, or 72 hours in culture.
doi:10.1371/journal.pone.0011502.t001
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tegmentum vasculosum and tectorial membranes were removed
prior to fixation in 4% PFA for 30 minutes. Basilar papillae were
cryoprotected overnight in 30% sucrose and then embedded in
PBS with 1% low melting point agarose and 18% sucrose. The
tissue was cryosectioned at 10 mm and then blocked and
permeabilized as described above. Sections were labeled for both
myosin VI and BrdU as previously described [12]. Sections were
then incubated with rabbit anti-myosin VI (1:350, Proteus,
Ramona, CA) in blocking solution for one hour. After washing,
sections were then incubated in Alexa Fluor 546 conjugated anti-
rabbit secondary antibodies (1:1,000, Invitrogen, Carlsbad, CA)
for one hour. After washing, basilar papilla sections were post-
fixed in 4% PFA for one hour. The cryosections were then washed
in PBS before 20 minute 2M HCl treatment to expose BrdU.
After thorough washing, sections were incubated with mouse anti-
BrdU antibodies (1:40, BD, Franklin Lakes, NJ) for one hour.
After 3 additional PBS washes, sections were incubated with Alexa
Fluor 647 conjugated anti-mouse secondary antibodies (Cell
Signaling Technology, Danvers, MA) for one hour. After thorough
washing, sections were mounted on glass slides in Vectashield
fluorescent mounting medium (Vector Laboratories, Burlingame,
CA). Images were captured using a Zeiss LSM 510 confocal
microscope.
Results and Discussion
Differential expression of genes in the forskolin and
control groups increases as a function of time
We report here a systematic comparison of genome-wide
expression between proliferating and non-proliferating chick
auditory epithelia using Affymetrix whole genome chicken
microarrays. The forskolin-induced proliferation paradigm was
chosen for this study given the robustness of the effect, which we
reasoned would facilitate identification of the molecular events
resulting in the production of new hair cells. RNA was isolated
from control and forskolin-treated samples cultured for 24, 48 and
72 hours. BrdU incorporation, a marker for S-phase entry, is seen
at 72 hours in the forskolin paradigm. Since S-phase entry is the
criterion that distinguishes the avian epithelium from that in
mammals, we have concentrated our analysis on this time point.
The isolated RNA from proliferating and non-proliferating
auditory epithelia was amplified, biotinylated, hybridized to
Affymetrix chicken arrays and scanned as described. The
normalized data were then filtered by expression to exclude all
probes that were expressed below 20% of the maximum
expression level in at least one of the samples at each time point.
This measure was taken to ensure that differential expression of
genes expressed at very low levels were not assigned a
disproportionate amount of significance. 32,509 out of 38,535
probes in the microarray met this initial criterion in the 72-hour
samples (Table 2). Of the 32,509 filtered probes, 5,032 had a
corrected p-value less than 0.05 at 72 hours. Of these 5,032 genes,
2,824 had at least a two-fold change in expression, which was used
as a criterion for functional significance. The same statistics from
the 24- and 48-hour samples are also shown in Table 2. A
proportional Venn diagram clearly shows differential expression of
far more genes at 72 hours than at 24 or 48 hours, but expression
of most of the genes differentially expressed at the two earlier time
points are also affected at 72 hours (Figure 1). It is not surprising
that far fewer genes are differentially expressed at 24 and 48 hours
than at 72 hours, given that there must be some latency following
exposure to forskolin before gene expression is affected. A heat
map revealed that directionality of fold-changes for specific genes
remained fairly consistent at 24, 48, and 72 hours (Figure 2).
There also appeared to be a general trend toward larger fold-
change differences at the two later time points.
Many genes thought to be related to cellular proliferation and
inner ear development were differentially expressed between the
two conditions at multiple time points (Table 3). The complete lists
of genes differentially expressed between the control and forskolin
conditions at 24, 48, and 72 hours are included as Supporting
Information (Tables S1, S2, and S3, respectively). Given that
cellular proliferation is first observed in the basilar papilla at
72 hours in culture with forskolin, the following discussion will
focus on data from this particular time point. One gene that is
differentially expressed after 72 hours of exposure to forskolin is
cyclin I (CCNI), a cell cycle regulator, which is over three-fold
Table 2. Microarray analysis statistics.
24 H 48 H 72 H
Statistical
Filtering
Number of
Probe Sets
Probe Sets
F.C
Probe Sets
F,C
Number of
Probe Sets
Probe Sets
F.C
Probe Sets
F,C
Number of
Probe Sets
Probe Sets
F.C
Probe Sets
F,C
Total 38,535 38,535 38,535
Expression above
background
a
31,692 31,793 32,509
Corrected p,0.05 46 25 5,032
.1.5-fold (of
p,0.05 list)
41 9 32 25 7 18 4,313 2,236 2,077
.2-fold (of
p,0.05 list)
39 9 30 24 6 18 2,824 1,291 1,533
.3-fold (of
p,0.05 list)
28 3 25 20 2 18 1,302 432 870
.4-fold (of
p,0.05 list)
26 3 23 18 1 17 760 194 566
aThe entire gene expression data set was filtered to exclude probes whose expression was not at least 20% in at least one out of the six 24-hour samples (24 H), six 48-
hour samples (48 H), or twelve 72-hour samples (72 H). The statistics reported are based only on those probes that met this criterion. Half of the samples from each
time point were treated with forskolin (F) and the remainder served as controls (C). Showed in boldface are the statistics for the list of genes defined to be differentially
expressed using p,0.05 and fold-change .2.
doi:10.1371/journal.pone.0011502.t002
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downregulated in proliferating murine cardiomyocytes (Table 3)
[51]. Wnt5a is underexpressed in regenerating tissue, a noteworthy
observation as inactivation of this gene has been linked to cellular
proliferation in a particular form of leukemia [52]. Wnt proteins
are also thought to play a role in the development of the lateral
line in zebrafish (reviewed in [53]) and chicken inner ears
[54,55,56]. Frizzled homolog 10, a gene likely to play a role in
cellular proliferation, is over 15-fold overexpressed in proliferating
versus non-proliferating tissue after 72 hours in culture [57].
Differential gene expression is confirmed by qPCR
Quantitative PCR (qPCR) was performed on select genes in
order to validate the microarray data. Primers were designed for
twelve genes that were found by microarray to be differentially
expressed between the two conditions at 72 hours; seven genes
were upregulated and five were downregulated in the forskolin
condition. QPCR confirmed the directionality of the microarray
findings for nine out of the twelve genes tested (75%). The fold-
changes of these nine genes were all significantly different from
one (95% confidence interval, data not shown), confirming their
differential expression as detected by microarray. These findings
validate the initial microarray results, so further analyses were
performed on the gene expression data set.
Curated gene set enrichment results
Our initial analysis of expression of individual genes that were
differentially expressed revealed that many are known to be
involved in control of the cell cycle and hair cell differentiation. To
more systematically identify genes that were correlated with
specific phenotypes, we used gene set enrichment analysis (GSEA),
a computational method to determine the expression of genes
associated with specific empirically determined phenotypes. Gene
sets packages were downloaded from the Broad Institute website
and were used for GSEAs on the Affymetrix expression data from
24, 48, and 72 hours (Table 1). An additional GSEA was
performed comparing the microarray data from the 24-hour
control samples to that in the 72-hour control samples to serve
as a negative control for changes in gene expression resulting from
the culture conditions rather than exposure to forskolin. This
GSEA produced no significantly (FDR ,0.25 and p-value ,0.05)
enriched gene sets for any of the three gene set packages used (data
not shown).
To assess the functional relevance of the genes that were
differentially expressed, a GSEA was performed using manually
curated gene sets downloaded from the Broad Institute website.
Thispackage contains sets of genes found by individual experiments
to be associated with specific phenotypes. The complete GSEA
results for all utilized gene sets in this and all subsequent GSEAs are
included as Supporting Information (Tables S4, S5, S6, S7, S8, S9,
S10, S11, S12). Consistent with our observation of individual gene
expression, the GSEA performed using curated gene sets showed
that in forskolin treated basilar papillae many gene sets associated
with cell cycle control are significantly enriched at various time
points. For example, at 24, 48, and 72 hours there is enrichment of
the following gene sets: SERUM_FIBROBLAST_CELLCYCLE
[58], HSA04110_CELL_CYCLE [59], [60,61], CELL_CYCLE
[62], CELL_CYCLE_KEGG [59,60,61], GOLDRATH_CELL-
CYCLE [63], CELL_CYCLE_ CHECKPOINT, G1_TO_S_
CELL_CYCLE_REACTOME [64], and BRENTANI_CELL_
CYCLE [65] in explants exposed to forskolin (Table 4). The
enrichment statistics for all gene sets used in this GSEA are included
as Supporting Information (Tables S4, S5, S6). These findings are
expected and instill confidence about the rest of the enrichment
analysis results, given that forskolin treatment is known to stimulate
S-phase entry in normally quiescent cells [22,23].
The GSEA based on the curated gene sets also revealed that
targets of E2F1, a transcription factor known to be important for cell
cycle control, in human primary fibroblast cells identified by ChIP
analysis (REN_E2F1_TARGETS [66]) are enriched in the prolifer-
ating auditory epithelia at both 48 and 72 hours. Further, a set of
genesinthe retinoblastoma pathway identified by microarray analysis
in human cell lines (VERNELL_PRB_CLSTR1 [67]) was found to
be significantly enriched after 24, 48, and 72 hours in culture with
forskolin. These findings further underscore the potentially important
role of the E2F1 transcription factor and the retinoblastoma protein
pathway in auditory hair cell regeneration.
A particularly interesting result of the GSEA using the curated
gene sets is the observation that a set of genes found to be
upregulated in mouse embryonic, neural and hematopoietic stem
cells (HSC) relative to differentiated brain and bone marrow cells
(STEMCELL_COMMON_UP [68]) is also enriched in the
basilar papilla after culture with forskolin for 24, 48, or 72 hours.
Further, a set of genes found to be downregulated in stem cells
(STEMCELL_COMMON_DN [68]) in the same study were also
enriched in the quiescent tissue relative to proliferating tissue after
48 or 72 hours in culture, suggesting that genes downregulated in
stem cells are also downregulated in the proliferating basilar
papilla.
Though not widely accepted, there is evidence for the existence
of stem cells within the postnatal organ of Corti [69]. Additionally,
approximately 4% of supporting cells show stem cell-like behavior
Figure 1. Far more genes were differentially expressed at
72 hours than at 24 or 48 hours of exposure to forskolin.
Shown is a proportional Venn diagram indicating the number of genes
significantly (p,0.05 and fold change .2) differentially expressed at 24,
48, and 72 hours of exposure to forskolin. The number of genes in each
category is indicated in parentheses. Far more genes are affected at
72 hours than at either of the two earlier time points. A little over half of
the genes differentially expressed at 24 or 48 hours are also
differentially expressed at 72 hours. Only one gene, AMPH, was affected
at all three time points.
doi:10.1371/journal.pone.0011502.g001
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has shown that murine embryonic and induced pluripotent stem
cells retain the capacity to differentiate into mechanosensitive cells
which resemble immature hair cells [71]. It is interesting that
genes found to be upregulated in HSCs specifically are also
upregulated in proliferating basilar papillae given that HSCs are
thought to remain in a state of quiescence until stimulated to
proliferate by external signals [72,73]. The chick basilar papilla is
also quiescent until injury stimulates regeneration of hair cells by
signals that have not yet been identified. It is therefore very
interesting that proliferating basilar papillae overexpress genes that
are also overexpressed in HSCs [68]. If the basilar papilla does in
fact possess stem cells that share some properties with HSCs then it
may be possible to stimulate the production of new hair cells using
signals known to induce normally quiescent HSCs to proliferate.
These results are consistent with the hypothesis that in forskolin
treated basilar papillae some supporting cells are stimulated to
dedifferentiate and express stem cell markers, prior to division and
production of new hair cells.
I ti sw o r t hn o t i n gt h a ta t2 4a n d4 8h o u r sa f t e re x p o s u r et o
forskolin, there is enrichment of the following curated gene sets, all of
which are associated with cell death and/or apoptosis: BRENTA-
NI_DEATH [65], HSA04210_APOPTOSIS [59,60,61], APOPTO-
SIS [64], APOPTOSIS_GENMAPP [64]. There is also enrichment
of the gene set PASSERINI_APOPTOSIS [74] after 48 hours of
exposure to forskolin. It is believed that forskolin induces proliferation
in the inner ear without injury and subsequent regeneration, but this
has never been definitively proven. However, the proliferation that is
seen in the basilar papilla following exposure to forskolin is more
robust than that seen following exposure to gentamicin, which causes
hair cell death and regeneration [22]. Unpublished experiments
performed for the same paper also did not show a qualitative loss of
hair cells at 24, 48, or 72 hours, whereas hair cell ejection from the
basilar papilla is seen as early as 30 hours following subcutaneous
administration of gentamicin [75]. Markers of cell death in avian hair
cells can appear even earlier following injury and begin with TIAR
translocation as early as 12 hours after injury, before caspase
activation which can occur as early as 30 hours after injury [76,2].
Our gene expression data do not show differential expression of key
markers of hair cell death such as caspase-3 and caspase-9 [76].
Regardless, the GSEA results suggest a possible contribution of
apoptosis in forskolin induced proliferation in the avian inner ear. As
the aim of the present study was to identify novel genes and pathways
important for the production of new hair cells in deafened animals, the
reported findings are of considerable interest regardless of a possible
contribution of injury with subsequent regeneration in the forskolin-
induced proliferation model of hair cell regeneration. Additional work
will be needed to determine just how m u c h ,i fa n y ,o ft h i sp r o l i f e r a t i o n
is in fact the result of injury to the auditory epithelium.
Mammalian gene set enrichment results
To determine which miRNAs were likely upregulated to give
rise to the observed pattern of differential gene expression detected
by microarray, an additional GSEA was performed using the
mammalian gene sets which are based on genomic conservation
between the human, rat, mouse, and dog genomes. These gene
sets were used on our chicken gene expression data because they
included not only transcription factor binding site, but also
Figure 2. Fold-change differences of selected genes of interest remain stable at 24, 48, and 72 hours. Shown is a heat map depicting
fold-changes between the forskolin and control conditions for a set of genes of interest the three time points indicated. The genes shown were
selected because of their known expression in the inner ear (i.e., RARB, CALB1, OCM), ion channel identity (e.g., KCNAB1, KCNJ15), or relevance to the
present study (i.e., E2F1). The genes span a range of fold-changes and are both up and downregulated with forskolin treatment. Fold-changes are
given as log2(expression in forskolin/expression in control). The directionality of fold-changes was fairly consistent across time points, but there was a
slight general trend toward increasing fold-change values from 24 to 72 hours.
doi:10.1371/journal.pone.0011502.g002
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species [42]. Using these mammalian gene sets and a false
discovery rate cut-off of 0.25 as suggested by [40], 210 out of 783
gene sets were significantly enriched in the control condition and
37 in the forskolin condition at 72 hours (Table 1). As a negative
control, enrichment of predicted targets of the transcription factor
PAX6 was examined, given its known role in retinal development
[77,78] and absence of expression in the developing chicken inner
ear [79]. That a pathway thought not to be important in the inner
ear was not activated by forskolin exposure underscores that
significantly enriched gene sets reflect real changes in gene
expression (Supporting Information).
The difference in the number of gene sets associated with the
control and forskolin conditions is striking, and it is worth pointing
out that many of the gene sets associated with the control
condition are miRNA gene sets, each of which represents a group
of genes that are predicted targets of a specific miRNA. The
association of these sets with the control condition implies that the
miRNA target genes are down-regulated following forskolin
treatment. Thus, we hypothesize that these miRNAs are
upregulated in the forskolin group. We put forward this entire
set of miRNAs as candidates whose role in hair cell regeneration
and cellular proliferation warrants further investigation. Specific
miRNAs and transcription factors of interest based on our analysis
using the mammalian gene sets are presented in Table 5. A
complete list of all significantly enriched gene sets from this
analysis are included in the Supporting Information section
(Tables S7, S8, S9).
Table 3. QPCR validation of gene expression data.
Microarray
24 Hours
Microarray
48 Hours
Microarray
72 Hours
qPCR
72 Hours
Gene symbol
Median Fold-
Change
(F/C)
Corrected p
Value
Median Fold-
Change
(F/C)
Corrected p
Value
Median Fold-
Change
(F/C)
Corrected p
Value
Average Fold-
Change
(F/C)
CCNI 1/1.68 0.26 1/2.46 0.28 1/3.00 5.22E-05 1/1.54
1/2.24 0.27 1/4.59 0.25 1/3.31 0.0017
1/2.57 0.23 1/3.32 0.33 1/3.44 0.0035
1/2.27 0.23 1/2.90 0.34 1/4.21 3.63E-04
WNT5a 1/3.88 0.15 1/2.56 0.41 1/2.31 0.017
WNT3 1.26 0.40 1.90 0.41 2.81 .023
FZD10 1.28 0.86 1/1.34 0.88 15.48 0.0092
BECN1 1.05 0.88 1.65 0.37 2.04 0.051 1.66
1.39 0.27 1.37 0.50 1.61 0.15
CDC45L 3.15 0.34 6.19 0.51 3.16 0.14
DPM1 1.10 0.79 1.51 0.19 2.40 5.00E-04 1/1.11
1.17 0.52 1.47 0.51 2.15 0.0024
SNX1 1.69 0.21 1.22 0.39 2.65 7.07E-04 5.62
EME1 1.03 0.27 1.03 0.65 5.29 0.0032 1.38
1.99 0.25 3.52 0.36 1.08 0.31
FBXO8 1.03 0.27 2.02 0.22 3.42 0.0072 1.96
1/1.99 0.25 2.05 0.37 2.16 0.031
PIGW 2.09 0.041 2.58 0.33 4.30 6.38E-04 1.64
CDH20 1/1.11 0.87 1/1.28 0.56 1/8.20 0.0018 1/8.11
1.13 0.89 1/2.19 0.51 1/22.25 4.52E-05
ITGA4 1.09 0.36 1/1.18 0.51 1/1.06 0.47 1/3.67
1/1.87 0.080 1/1.40 0.49 1/2.08 0.089
1.16 0.47 1/1.42 0.51 1/2.28 0.055
NLGN1 1.06 0.30 1/1.12 0.51 1.02 0.43 1/1.46
1.08 0.27 1/1.08 0.51 1/1.01 0.87
1/5.92 0.23 1/3.90 0.15 1/1.25 0.45
1/2.58 0.27 1/3.08 0.51 1/2.11 0.0046
1.06 0.28 1/1.05 0.51 1/2.99 0.011
CDKN1B (p27) 1/1.27 0.30 1/2.97 0.49 1/2.12 0.015 2.64
1/1.77 0.15 1/1.72 0.22 1/2.21 9.92E-04
OCM 1/1.27 0.307 1/153.66 0.14 1/64.33 1.81E-04 1/13.45
QPCR and microarray data for individual genes of interest and genes selected for qPCR validation as described in the text. Multiple microarray values represent different
probe sets for the same gene.
doi:10.1371/journal.pone.0011502.t003
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Gene Set
Enriched
at 24H
24H
P-Value
24H
FDR
Enriched
at 48H
48H
P-Value
48H
FDR
Enriched
at 72H
72H
P-Value
72H
FDR
SERUM_FIBROBLAST_CELLCYCLE Forskolin 0.012 0.053 Forskolin ,0.001 ,0.001 Forskolin ,0.001 ,0.001
HSA04110_CELL_CYCLE Forskolin 0.002 0.014 Forskolin ,0.001 ,0.001 Forskolin ,0.001 ,0.001
CELL_CYCLE Forskolin ,0.001 0.004 Forskolin ,0.001 ,0.001 Forskolin ,0.001 ,0.001
CELL_CYCLE_KEGG Forskolin ,0.001 0.004 Forskolin ,0.001 ,0.001 Forskolin ,0.001 ,0.001
GOLDRATH_CELLCYCLE Forskolin 0.018 0.061 Forskolin ,0.001 ,0.001 Forskolin ,0.001 0.002
CELL_CYCLE_CHECKPOINT Forskolin ,0.001 0.003 Forskolin 0.002 0.008 Forskolin ,0.001 0.003
G1_TO_S_CELL_CYCLE_REACTOME Forskolin ,0.001 0.002 Forskolin 0.006 0.023 Forskolin 0.013 0.054
BRENTANI_CELL_CYCLE Forskolin ,0.001 0.004 Forskolin ,0.001 ,0.001 Forskolin 0.018 0.059
HSA04330_NOTCH_SIGNALING_PATHWAY Forskolin 0.577 0.679 Forskolin 0.037 0.084 Forskolin 0.896 0.949
STEMCELL_COMMON_UP Forskolin ,0.001 0.001 Forskolin ,0.001 ,0.001 Forskolin ,0.001 ,0.001
STEMCELL_COMMON_DN Control 0.107 0.294 Control ,0.001 0.022 Control ,0.001 0.008
REN_E2F1_TARGETS Forskolin 0.141 0.278 Forskolin 0.002 0.007 Forskolin ,0.001 0.001
VERNELL_PRB_CLSTR1 Forskolin 0.006 0.054 Forskolin ,0.001 ,0.001 Forskolin ,0.001 ,0.001
BRENTANI_DEATH Forskolin ,0.001 0.004 Forskolin 0.039 0.094 Forskolin 0.853 0.914
HSA04210_APOPTOSIS Forskolin ,0.001 0.017 Forskolin 0.004 0.012 Forskolin 0.016 0.049
APOPTOSIS Forskolin 0.002 0.010 Forskolin 0.004 0.044 Control 0.308 0.454
APOPTOSIS_GENMAPP Forskolin 0.016 0.052 Forskolin 0.002 0.019 Forskolin 0.146 0.256
PASSERINI_APOPTOSIS Forskolin 0.085 0.207 Forskolin 0.015 0.034 Control 0.045 0.132
Shown are the curated gene set enrichment analysis results for selected gene sets of interest at 24, 48, and 72 hours. The gene sets shown here were downloaded from
the BROAD Institute website and represent empirically defined sets of genes. References for each gene set are provided in the text. Italicized are those gene sets with p-
value ,0.05 and false discovery rate (FDR) ,0.25, which are taken as significant. Gene sets are directly as they appear in the Molecular Signatures Database on the
Broad Institute website.
doi:10.1371/journal.pone.0011502.t004
Table 5. Mammalian gene set enrichment analysis results.
Gene Set
Enriched
at 24H
24H
P-Value
24H
FDR
Enriched
at 48H
48H
P-Value
48H
FDR
Enriched
at 72H
72H
P-Value
72H
FDR
TGAATGT,MIR-181A,MIR-181B,MIR-
181C,MIR-181D
Forskolin 0.475 1 Forskolin 0.001 0.009 Control ,0.001 0.001
ACTGTGA,MIR-27A,MIR-27B Forskolin 0.238 1 Forskolin 0.406 1 Control 0.002 0.042
CAGTGTT,MIR-141,MIR-200A Control 0.683 1 Forskolin 0.017 0.648 Control 0.002 0.031
V$E2F_Q6 Forskolin 0.033 0.273 Forskolin 0.001 0.015 Forskolin 0.004 0.035
V$E2F1_Q6 Forskolin 0.003 0.009 Forskolin 0.003 0.102 Forskolin ,0.001 0.034
V$E2F_Q4 Forskolin 0.014 0.064 Forskolin 0.002 0.056 Forskolin 0.008 0.064
V$E2F_Q4_01 Forskolin 0.014 0.064 Forskolin 0.001 0.003 Forskolin 0.019 0.121
V$E2F1_Q3 Forskolin 0.126 0.994 Forskolin 0.014 0.53 Forskolin 0.006 0.121
SGCGSSAAA_V$E2F1DP2_01 Forskolin 0.056 0.733 Forskolin 0.008 0.301 Forskolin 0.014 0.121
V$E2F1DP2_01 Forskolin 0.055 0.549 Forskolin 0.001 0.016 Forskolin 0.031 0.14
V$E2F1_Q4_01 Forskolin 0.254 1 Forskolin 0.001 0.016 Forskolin 0.016 0.142
V$E2F4DP1_01 Forskolin 0.055 0.677 Forskolin 0.002 0.062 Forskolin 0.016 0.137
V$E2F_02 Forskolin 0.056 0.601 Forskolin 0.001 0.016 Forskolin 0.016 0.132
V$E2F1DP1RB_01 Forskolin 0.033 0.35 Forskolin 0.001 0.003 Forskolin 0.02 0.14
V$E2F1DP1_01 Forskolin 0.055 0.771 Forskolin 0.001 0.018 Forskolin 0.024 0.139
V$E2F1_Q6_01 Forskolin 0.003 0.009 Forskolin 0.007 0.256 Forskolin 0.073 0.224
V$E2F_Q3 Forskolin 0.194 1 Forskolin 0.002 0.069 Forskolin 0.068 0.227
Shown are the mammalian gene set enrichment analysis results for selected gene sets of interest at 24, 48, and 72 hours. Italicized are those gene sets with p-value ,
0.05 and false discovery rate (FDR) ,0.25, which are taken as significant. Gene sets are directly as they appear in the Molecular Signatures Database on the Broad Institute
website.
doi:10.1371/journal.pone.0011502.t005
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interesting candidates for further study given what is already
known about their function. For example, miR141 and miR200a
are expressed in the chicken inner ear epithelium, and are
important regulators of epithelial-mesenchymal transition [30,80].
It is also interesting that the miR27 family showed up as one of the
most significant gene sets in this particular analysis given the
known role of this miRNA in cellular proliferation. Specifically,
downregulation of this miRNA seems to decrease proliferation in
the context of hepatic stellate cell activation, an early event in liver
fibrosis [81]. MiR27a is overexpressed in human gastric
adenocarcinoma, and inhibition of this miRNA limits proliferation
[82]. Another study has also shown that the oncogenic activity of
miR27a in human breast cancer cells is likely due to downreg-
ulation of genes controlling the G2-M cell-cycle checkpoint [83].
MiR181a is known to be expressed in the mammalian inner ear
[28], and has a pro-proliferative role in human leukemia cells,
which appears to be mediated by suppression of the cell cycle
inhibitor p27 [33]. Given the abundance and nature of evidence
for a role of miR181a, miR27a, and miR141/miR200a in cellular
proliferation or inner ear development, we put these forward as
particularly intriguing candidates for further study within the
context of auditory hair cell regeneration.
Chicken/frog gene set enrichment analysis
While the primary goal of the GSEA with the mammalian gene
sets was to identify miRNAs that may be important for hair cell
regeneration, interestingly some transcription factor gene sets were
found to be up- and downregulated in the forskolin condition. This
was surprising in light of the fact that these sets were based on
portions conserved across only selected mammalian genomes,
which were expected to differ significantly from gene sets based on
the chicken genome. To verify the up- and downregulation of
these gene sets in the chicken inner ear an additional GSEA was
performed using gene sets based on scanning the portions of the
chicken genome that are conserved with frog (Xenopus tropicalis)t o
look for enrichment of sets of genes sharing particular transcrip-
tion factor recognition sites obtained from the TRANSFAC
database. Using a q-value cutoff of 0.25 there were 41 gene sets
associate with forskolin treatment, and 331 gene sets associated
with forskolin treatment (see Table 1). The enrichment statistics
for all gene sets included in this analysis are presented as
Supporting Information (Tables S10, S11, S12). Of the six gene
sets that were significantly enriched in the forskolin condition, four
are sets of genes that share known E2F1 binding sites (Table 6).
Additionally, some E2F1 gene sets are significantly enriched in
forskolin treated tissue at 24 and 48 hours relative to untreated
controls (Table 6), suggesting that upregulation of predicted E2F1
targets occurs early after forskolin treatment and is sustained until
72 hours in culture, when new cells are first seen [22]. Many E2F/
E2F1 gene sets are also enriched in the forskolin treated tissue
when the mammalian gene sets (Table 5) are used to compare the
expression data from forskolin samples fixed after 24 and 72 hours
in culture, suggesting agreement between the GSEAs performed
using the mammalian gene sets and chicken/frog conservation
gene sets. The identification of E2F/E2F1 by both analyses
strongly suggests a role for this transcription factor in forskolin
induced proliferation in the chicken inner ear.
E2F1 is an intriguing candidate for further study given its
known role in cell cycle control (reviewed in [84]) and potential
role in inner ear development (reviewed in [85]). E2Fs bind
hypophosphorylated pRBs which then sequester these factors.
PRBs can be phosphorylated by cyclin-dependent kinases (CDKs),
rendering these proteins unable to bind E2Fs thereby releasing
these factors which then become transcriptionally active
[86,87,88]. Interestingly, overexpression of E2F1 has been shown
to induce quiescent REF-52 cells to enter S-phase [89]. E2F1
forms part of an ‘activating’ E2F complex that can interact with
pocket proteins (pRBs) to control the cell cycle [90]. E2F1
exclusively binds the pRB RB1, and peaks in expression during the
G1-S checkpoint [90]. Given the central role of E2Fs in cell cycle
control, our finding that genes targeted by E2F1 are enriched
among the genes that are overexpressed in the proliferating chick
inner ear suggests a role for this transcription factor in hair cell
regeneration.
Table 6. Conservation gene set enrichment analysis results.
Gene Set
Enriched
at 24H
24H
P-Value
24H
FDR
Enriched
at 48H
48H
P-Value
48H
FDR
Enriched
at 72H
72H
P-Value
72H
FDR
V$E2F_Q2 Forskolin ,0.001 ,0.001 Forskolin 0.006 0.016 Forskolin ,0.001 0.003
V$E2F1_Q3_01 Forskolin 0.038 0.066 Forskolin 0.017 0.063 Forskolin 0.024 0.415
V$E2F_03 Forskolin 0.099 0.176 Forskolin 0.071 0.144 Forskolin 0.012 0.038
V$E2F1DP1RB_01 Forskolin 0.793 0.840 Forskolin 0.905 0.933 Forskolin 0.019 0.057
V$E2F1_Q4_01 Forskolin 0.345 0.430 Forskolin 0.573 0.639 Forskolin 0.041 0.096
V$E2F_Q3 Forskolin 0.342 0.416 Forskolin 0.418 0.532 Forskolin 0.038 0.101
V$E2F_Q3_01 Forskolin 0.681 0.734 Forskolin 0.416 0.483 Forskolin 0.038 0.108
V$E2F_Q4 Forskolin 0.175 0.249 Forskolin 0.365 0.456 Forskolin 0.040 0.108
V$E2F1_Q6_01 Forskolin 0.422 0.477 Forskolin 0.245 0.332 Forskolin 0.058 0.115
V$E2F1_Q3 Forskolin 0.511 0.564 Control 0.306 0.437 Forskolin 0.077 0.155
V$E2F_Q6 Forskolin 0.964 0.965 Control 0.714 0.832 Forskolin 0.073 0.155
V$E2F1_Q6 Forskolin 0.330 0.395 Forskolin 0.245 0.332 Forskolin 0.079 0.152
Shown are the results of the conservation gene set enrichment analysis performed on gene expression data from 24, 48, and 72 hours in culture. These analyses were
performed using gene sets based on transcription factor motifs in regions conserved between the chicken and frog genomes. The gene sets shown here were
downloaded from the BROAD Institute website and represent empirically defined sets of genes. References for each gene set are provided in the text. Italicized are
those gene sets with p-value ,0.05 and false discovery rate (FDR) ,0.25, which are taken as significant. Gene sets are directly as they appear in the Molecular Signatures
Database on the Broad Institute website.
doi:10.1371/journal.pone.0011502.t006
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PLoS ONE | www.plosone.org 10 July 2010 | Volume 5 | Issue 7 | e11502Figure 3. MicroRNA181a overexpression produces proliferation in the chicken basilar papilla. Basilar papillae from 0-day-old chicks were
cultured for 72 hours in the presence of BrdU, the nuclear incorporation of which was detected by antibody labeling. In A–E sensory epithelia are
outlined with dashed white lines. The neural edge of each epithelium is at the bottom, the abneural edge is at the top, the distal end is to the right
and the proximal end is to the left of the image. BrdU-positive (i.e., recently divided) cells are immunohistochemically labeled and appear as purple
dots. Individual cochleas were treated with 100 nM pre-miR181a (A), 100 mM forskolin (FSK) (B), FSK + 100 nM pre-miR181a (C), 100 mM FSK+ 100 nM
anti-miR181a (D), or DMSO as a vector control (E). A pro-proliferative effect of miR181a can be appreciated. Further, knocking down endogenous
miR181a appears to have a large suppressive effect on forskolin induced proliferation. Transfection was achieved in the first 24 hours of culture using
X-tremeGENE siRNA Transfection Reagent in accordance with the manufacturer’s instructions (Roche, Indianapolis, IN). The miRNA containing media
was removed after 24 hours and replaced with normal medium. The summary of the average number of BrdU positive cells for the control (n=7),
miR181a (n=8), forskolin (n=8), forskolin + miR181a (n=8), and forskolin + anti-miR181a (n=3) conditions. The following comparisons were all
statistically significant: control versus miR181a (p=0.001), control versus forskolin (p,0.001), miR181a versus forskolin (p,0.001), forskolin versus
forskolin plus anti-miR181a (p=0.008) and forskolin versus forskolin plus miR181a (p=0.005). Scale bars in panels A–E=0.2 mm.
doi:10.1371/journal.pone.0011502.g003
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Of all the miRNAs whose predicted targets were significantly
enriched in control relative to forskolin treated basilar papillae,
miR181a was specifically selected for functional studies in light of its
high level of statistical significance, known expression in the
developing mammalian inner ear [28], and pro-proliferative role
in human leukemia cells, which appears to be mediated by
suppression of the cell cycle inhibitor p27 [33]. To test whether
miR181a overexpression is sufficient to stimulate proliferation,
chick basilar papilla explants were transfected with either pre-
miR181a, which is converted to mature miR181a within cells, or a
non-targeting negative control miRNA. Incorporation of the
thymidine analog BrdU was used to assay proliferation. Basilar
papillae transfected with pre-miRNA had on average 68.75 (+/2
SEM=13.54) BrdU positive cells, significantly more than organs
transfected with a non-targeting miRNA which averaged only 7.00
(+/2 SEM=10.23) BrdU positive cells (p,0.01, Figure 3).
MiR181a overexpression is therefore sufficient to stimulate
proliferation in the normally quiescent chick auditory epithelium.
Basilar papillae cultured with forskolin for 72 hours and
transfected with a non-targeting miRNA had on average 178.25
(+/2 SEM=19.02) BrdU positive cells, significantly more than is
seen with miR181a overexpression (p,0.05) which suggests that
miR181a upregulation may account for only a portion of
forskolin’s mitogenic effect (Figure 3). To determine whether
miR181a expression is necessary for forskolin induced prolifera-
tion, some basilar papillae were cultured with forskolin for
24 hours, then transfected with anti-miR181a to suppress
endogenous miR181a, then cultured with forskolin for an
additional 24 hours. Basilar papillae transfected with only anti-
miR181a without forskolin treatment had an average of only 14
(+/2 SEM=3.06) BrdU positive cells per epithelium, not
significantly different from controls. Basilar papillae exposed to
forskolin and transfected with anti-miR181a had an average of
67.33 (+/2 SEM=13.38) BrdU positive cells, significantly less
than the basilar papillae that were cultured with forskolin and
transfected with a negative control miRNA (p,0.01), suggesting
that endogenous miR181a contributes to the pro-proliferative
effect of forskolin in the chick inner ear.
To see whether miR181a could enhance the already robust pro-
proliferative effect of forskolin, basilar papillae were transfected
with pre-miR181a and cultured in the presence of forskolin for
72 hours. These basilar papillae averaged 289.63 (+/2
SEM=28.04) BrdU positive cells per basilar papilla, which is
significantly higher than the forskolin effect alone (p,0.01). This
observation reaffirms the finding that endogenous miR181a is an
important mediator of forskolin induced proliferation in the chick
inner ear and is limited in part by the ability of forskolin to
stimulate upregulation of miR181a.
Given the observation that miR181a overexpression is sufficient
to stimulate proliferation in the chick auditory epithelium, basilar
papillae were transfected with pre-miR181a or nontargeting
negative control miRNA and then cryosectioned and labeled for
BrdU and the early myosin VI to determine whether any of the
newly produced BrdU positive cells express the early hair cell
marker. As is seen in Figure 4, some cells labeling for BrdU
72 hours after transfection with pre-miR181a are located at the
most apical portion of the basilar papilla, an area occupied by only
hair cells and thin supporting cell processes. Further, some cells
with nuclear BrdU labeling also have cytoplasmic myosin VI
labeling. No such co-labeling cells were observed in basilar
papillae transfected with a non-targeting miRNA. These results
Figure 4. Some new cells produced by miR181a transfection express the early hair cell marker myosin VI. Shown is a confocal image of
a basilar papillae that was transfected with pre-miR181a, cultured for 72 hours, then cryosectioned and labeled for BrdU (blue) and the early hair cell
marker myosin VI (red) (A). The apical surface of hair cells is to the left of the image and the neural edge of the basilar papillae is toward the bottom.
The tectorial membrane has been removed to allow for antibody labeling. The inset of A is also shown in panels B (myosin VI), C (BrdU) and D
(merge). The arrow in D shows a cell that expresss myosin VI and has a BrdU positive nucleus, whereas the arrowhead shows a cell that is labeling for
myosin VI but not BrdU. The double-labeled cell is one that has been stimulated to divide and subsequently begin differentiating toward a hair cell
phenotype. The scale bar in B also applies to C and D.
doi:10.1371/journal.pone.0011502.g004
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new hair cells.
It is not surprising that a single miRNA is able to stimulate S-
phase entry in the avian auditory epithelium given the mounting
evidence that miRNAs can affect cell cycle regulation in a variety
of systems. MiR181a specifically has been shown to have a pro-
proliferative effect in human myeloid leukemia cells [33].
Interestingly, this effect appears to be mediated in part by
producing downregulation of p27, which may represent a barrier
to hair cell regeneration in the mammalian cochlea [34,35,91,92].
There is also evidence that many different miRNAs, including
miR181a, are expressed in the developing mouse inner ear [28].
Despite these findings, studies on the role of miRNA in hair cell
regeneration are limited in number and scope. One study revealed
that the let-7 family of miRNA is downregulated in the
regenerating newt auditory epithelium [32]. An interesting
translational correlate to this finding is that let-7 reduces tumor
growth in a rodent model of lung cancer, providing additional
evidence for the antiproliferative effects of this particular family of
miRNA [93]. Studies such as these underscore the importance of
examining more closely the role of miRNA in hair cell
regeneration, as induced underexpression of antiproliferative
genes may ultimately allow regeneration of hair cells in mammals.
In summary, we have identified a possible role for miR181a
in avian auditory hair cell regeneration. We have further
identified additional miRNAs and transcription factors as
candidates that warrant further investigation as potential
targets for therapeutics aimed at replacing lost hair cells.
Presented additionally are results suggestive of the presence of
stem cells with properties similar to HSCs in the regenerating
chick inner ear. Of all the candidates identified miR181a is
specifically put forward for further study in in-vivo mammalian
models of induced hearing loss in light of its demonstrated
proliferative effect in the chicken inner ear as well as the fact
that a miRNA based therapeutic could potentially be locally
delivered to the middle ear and passively absorbed through the
round window. This scenario seems plausible given that small
molecules such as gentamicin can be delivered to the inner ear
of patients in this fashion [94]. Computational analyses of our
gene expression data suggest that the transcription factor E2F1
may also play a role in hair cell regeneration when many
normally quiescent supporting cells are stimulated to re-enter
the cell cycle and divide prior to differentiating into new hair
cells. Additional functional studies will be necessary to
ultimately determine what ability, if any, these players have to
replace lost hair cells and result in recovery of compromised
hearing thresholds in mammals.
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